Cutaneous localized annular chromoblastomycosis

Journal of Cutaneous Pathology
Claudio G SalgadoJorge P da Silva

Abstract

Chromoblastomycosis (CBM) is a difficult-to-treat dermal mycosis characterized by the presence of round, pigmented, sclerotic bodies formed by black fungi found in polymorphic lesions. According to the morphology of a lesion, different clinical types of the disease have been described. We present three patients who each developed a single, 10-cm diameter, 8 to 15-year-old, well-circumscribed, slow-growing, annular, papulosquamous or papulosquamous-verrucous lesion, with no regression despite the use of topical antifungals. Skin scrapings and biopsies confirmed CBM and microculture defined the agent as Fonsecaea pedrosoi. The patients were treated with 200 mg/day of itraconazole for 6-9 months and were discharged after complete regression of the lesions. All were examined after the first and second year of the end of treatment and there were no signs of recurrence. A new clinical type of CBM is described, and itraconazole appears to be effective and safe in curing these patients after no more than 9 months of therapy.

References

Nov 1, 1992·International Journal of Dermatology·F Queiroz-TellesG Cauwenbergh
Feb 1, 1996·International Journal of Dermatology·T Rosen, M Overholt
May 1, 1997·Revista Do Instituto De Medicina Tropical De São Paulo·C de BedoutA Restrepo
Mar 22, 2001·Journal of the American Academy of Dermatology·R MinottoM L Scroferneker
Sep 1, 1950·Annals of the New York Academy of Sciences·A L CARRION
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Alexandro BonifazAmado Saúl
Apr 2, 2004·Revista Do Instituto De Medicina Tropical De São Paulo·Claudio Guedes SalgadoUbirajara Imbiriba Salgado
May 10, 2005·Diagnostic Microbiology and Infectious Disease·Mario F R Miranda, Ademir J G Silva
Jul 29, 2005·The Lancet Infectious Diseases·Claudio Guedes SalgadoUbirajara Imbiriba Salgado
Feb 21, 2006·Clinical and Experimental Dermatology·R Ungpakorn, S Reangchainam
Mar 4, 2006·Current Opinion in Infectious Diseases·Philippe Esterre, Flavio Queiroz-Telles
Jun 15, 2007·Indian Journal of Dermatology, Venereology and Leprology·Seema V PradhanSanjeev Gupta

❮ Previous
Next ❯

Citations

Aug 17, 2010·Annals of Dermatology·Young-Min SonYiel-Hea Seo
Aug 2, 2018·Anais Brasileiros De Dermatologia·Arival Cardoso de Brito, Maraya de Jesus Semblano Bittencourt
Jan 1, 2018·Anais Brasileiros De Dermatologia·Arival Cardoso de Brito, Fernanda Ventin Prates
Jul 14, 2010·Cytokine·Jorge Pereira da SilvaClaudio Guedes Salgado
Oct 13, 2021·Medical Mycology·Armando GuevaraRosane Christine Hahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Lancet Infectious Diseases
Claudio G SalgadoUbirajara I Salgado
Current Opinion in Infectious Diseases
Philippe Esterre, Flavio Queiroz-Telles
The Journal of Dermatological Treatment
Alexandro BonifazL Fierro-Arias
Revista Do Instituto De Medicina Tropical De São Paulo
Claudio G SalgadoUbirajara I Salgado
© 2022 Meta ULC. All rights reserved